TRxADE Health regains Nasdaq minimum bid price compliance; matter closed

Scienture Holdings, Inc.

Received Nasdaq Compliance Letter on July 7, 2023 confirming regained compliance with Bid Price Requirement (Rule 5550(a)(2)).
Closing bid price was at or above $1.00 for 10 consecutive business days from June 22 to July 6, 2023.
Previously disclosed non-compliance in December 2022; now considered closed by Nasdaq.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.